Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease

Steven Ng, Victor L. Villemagne, Sam Berlangieri, Sze-Ting Lee, Martin Cherk, Sylvia J. Gong, Uwe Ackermann, Tim Saunder, Henri Tochon-Danguy, Gareth Jones, Clare Smith, Graeme O'Keefe, Colin L. Masters and Christopher C. Rowe
Journal of Nuclear Medicine April 2007, 48 (4) 547-552; DOI: https://doi.org/10.2967/jnumed.106.037762
Steven Ng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor L. Villemagne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam Berlangieri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sze-Ting Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Cherk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia J. Gong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Ackermann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Saunder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Tochon-Danguy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gareth Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme O'Keefe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin L. Masters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Rowe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Amyloid-β (Aβ) imaging with N-methyl-11C-2-(4′-methylamino-phenyl)-6-hydroxy-benzothiazole (11C-6-OH-BTA-1; also known as 11C-PIB) shows a robust increase in cortical binding in Alzheimer's disease (AD). The aim of this study was to explore the clinical potential of Aβ imaging for the diagnosis of AD by comparison of the accuracy of visual reading of 11C-PIB images with quantitative analysis and 18F-FDG. Methods: Fifteen AD patients (age, 71.1 ± 11.3 y [mean ± SD]; mini-mental state examination [MMSE], 18.9 ± 9.3 [mean ± SD]) and 25 healthy control (HC) subjects (age, 71.9 ± 6.82 y; MMSE ≥ 28) underwent 90-min dynamic 11C-PIB PET and 20-min static 18F-FDG PET. 11C-PIB images, generated from data acquired between 40 and 70 min after injection, and 18F-FDG images were rated separately by 2 readers as normal, possible AD, or probable AD. Quantitative analyses used the distribution volume ratio (DVR) of frontal cortex, parietotemporal cortex, posterior cingulate, and caudate nucleus for 11C-PIB and standardized uptake value ratio (SUVR) of parietotemporal cortex and posterior cingulate for 18F-FDG, using cerebellar cortex as the reference region. Receiver-operating-characteristic (ROC) analysis was performed to compare the accuracy of quantitative measures. To determine the effect of age on diagnostic accuracy, the median age of the AD subjects (74 y) was chosen to separate the cohort into younger (64.4 ± 5.8 y) and older (78.6 ± 4.1 y) groups. Results: Visual agreement between readers was excellent for 11C-PIB (κ = 0.90) and good for 18F-FDG (κ = 0.56). 11C-PIB was more accurate than 18F-FDG both on visual reading (accuracy, 90% vs. 70%, P = 0.05) and ROC analysis (95% vs. 83%, P = 0.02). Accuracy declined more with 18F-FDG than with 11C-PIB in the older group. Conclusion: Visual analysis of 11C-PIB images appears more accurate than visual reading of 18F-FDG for identification of AD and has accuracy similar to quantitative analysis of a 90-min dynamic scan. The accuracy of 11C-PIB PET is limited by cortical binding in some healthy elderly subjects, consistent with postmortem studies of cerebral Aβ. Longitudinal follow-up is required to determine if this represents detection of preclinical AD.

  • Alzheimer's disease
  • amyloid-β
  • 11C-PIB
  • PET
  • 18F-FDG
  • brain imaging
View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (4)
Journal of Nuclear Medicine
Vol. 48, Issue 4
April 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
Steven Ng, Victor L. Villemagne, Sam Berlangieri, Sze-Ting Lee, Martin Cherk, Sylvia J. Gong, Uwe Ackermann, Tim Saunder, Henri Tochon-Danguy, Gareth Jones, Clare Smith, Graeme O'Keefe, Colin L. Masters, Christopher C. Rowe
Journal of Nuclear Medicine Apr 2007, 48 (4) 547-552; DOI: 10.2967/jnumed.106.037762

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
Steven Ng, Victor L. Villemagne, Sam Berlangieri, Sze-Ting Lee, Martin Cherk, Sylvia J. Gong, Uwe Ackermann, Tim Saunder, Henri Tochon-Danguy, Gareth Jones, Clare Smith, Graeme O'Keefe, Colin L. Masters, Christopher C. Rowe
Journal of Nuclear Medicine Apr 2007, 48 (4) 547-552; DOI: 10.2967/jnumed.106.037762
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Traumatic brain injury and Alzheimers Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)
  • Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases
  • First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
  • Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects
  • 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias
  • Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation
  • Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images
  • Visual-Statistical Interpretation of 18F-FDG-PET Images for Characteristic Alzheimer Patterns in a Multicenter Study: Inter-Rater Concordance and Relationship to Automated Quantitative Evaluation
  • Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging
  • Brain Amyloid Imaging
  • Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
  • Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
  • Brain Amyloid Imaging
  • Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
  • Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion
  • Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
  • Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
  • Comparison of 18F-FDG and PiB PET in Cognitive Impairment
  • Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias
  • Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
  • Voxel-Based Analysis of 11C-PIB Scans for Diagnosing Alzheimer's Disease
  • Role of imaging techniques in the diagnosis of dementia
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire